RAPID: Resource of Asian Primary Immunodeficiency Diseases by Keerthikumar, Shivakumar et al.
Published online 8 October 2008 Nucleic Acids Research, 2009, Vol. 37, Database issue D863–D867
doi:10.1093/nar/gkn682
RAPID: Resource of Asian Primary
Immunodeficiency Diseases
Shivakumar Keerthikumar
1,2,3, Rajesh Raju
1,2,3, Kumaran Kandasamy
1,3,4,
Atsushi Hijikata
5, Subhashri Ramabadran
1,2, Lavanya Balakrishnan
1,2,
Mukhtar Ahmed
1, Sandhya Rani
1, Lakshmi Dhevi N. Selvan
1, Devi S. Somanathan
1,
Somak Ray
1, Mitali Bhattacharjee
1, Sashikanth Gollapudi
1, Y. L. Ramachandra
3,
Sahely Bhadra
6, Chiranjib Bhattacharyya
6, Kohsuke Imai
7, Shigeaki Nonoyama
7,
Hirokazu Kanegane
8, Toshio Miyawaki
8, Akhilesh Pandey
1,4,
Osamu Ohara
5,9,* and Sujatha Mohan
1,2
1Institute of Bioinformatics, International Technology Park, Bangalore 560 066, India,
2Research Unit for
Immunoinformatics, Research Center for Allergy and Immunology, RIKEN Yokohama Institute, Kanagawa
230-0045, Japan,
3Department of Life Science, Kuvempu University, Jnanasahyadri, Shimoga 577 451, India,
4McKusick-Nathans Institute of Genetic Medicine and Departments of Biological Chemistry, Pathology and
Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA,
5Laboratory for
Immunogenomics, Research Center for Allergy and Immunology, RIKEN, Yokohama Institute, Kanagawa
230-0045, Japan,
6Department of Computer Science and Automation, Indian Institute of Science, Bangalore-12,
India,
7Department of Pediatrics, National Defense Medical College, Saitama 359-8513, Japan,
8Department of
Pediatrics, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194
and
9Department of Human Genome Technology, Kazusa DNA Research Institute, Chiba 292-0818, Japan
Received August 15, 2008; Revised September 21, 2008; Accepted September 23, 2008
ABSTRACT
Availability of a freely accessible, dynamic and
integrated database for primary immunodeficiency
diseases (PID) is important both for researchers as
well as clinicians. To build a PID informational plat-
form and also as a part of action to initiate a network
of PID research in Asia, we have constructed a web-
based compendium of molecular alterations in PID,
named Resource of Asian Primary Immunodefi-
ciency Diseases (RAPID), which is available as a
worldwide web resource at http://rapid.rcai.riken.
jp/. It hosts information on sequence variations
and expression at the mRNA and protein levels of
all genes reported to be involved in PID patients.
The main objective of this database is to provide
detailed information pertaining to genes and
proteins involved in primary immunodeficiency
diseases along with other relevant information
about protein–protein interactions, mouse studies
and microarray gene-expression profiles in various
organs and cells of the immune system. RAPID also
hosts a tool, mutation viewer, to predict deleterious
and novel mutations and also to obtain mutation-
based 3D structures for PID genes. Thus, informa-
tion contained in this database should help
physicians and other biomedical investigators to
further investigate the role of these molecules
in PID.
INTRODUCTION
Primary immunodeﬁciency diseases (PIDs) are a class of
disorders resulting from intrinsic defects in genes involved
in the development and maintenance of the immune
system. More than 150 primary immunodeﬁciency genes
are reported thus far, which are classiﬁed into eight diﬀer-
ent categories by the International Union of Immunologi-
cal Societies (1). Patients with these intrinsic defects have
increased susceptibility to recurrent and persistent infec-
tions, and they may also have autoimmune and cancer-
related symptoms. Most PIDs are rare and the diagnosed
patients for a given condition are often randomly spread
out around the world (2). The genetic defects that cause
PIDs can aﬀect the expression and function of proteins
that are involved in a range of biological process such as
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cascades and maintenance of immune homeostasis (3).
Recent advances in both diagnosis and therapeutic
modalities have allowed these defects to be identiﬁed
earlier and to be more precisely deﬁned, and they have
also resulted in more promising long-term outcomes (4).
Development of a freely accessible, dynamic and inte-
grated database with inclusion of genomics, transcrip-
tomics and proteomics data of all genes that are
involved in PID has the potential to further accelerate
research into PIDs as well as provide physicians with
easy access to pertinent clinical and molecular data that
is otherwise spread throughout the literature.
Resource of Asian Primary Immunodeﬁciency Diseases
(RAPID) is a web-based compendium of molecular altera-
tions in PIDs that is freely available to the academic
community at http://rapid.rcai.riken.jp. It hosts informa-
tion on the sequence variations mapped to the mRNA
and protein sequences for all the genes reported from
PID patients worldwide. Besides molecular alterations,
RAPID has the protein–protein interaction network
from Human Protein Reference Database (HPRD) (5),
a database with protein-centric information for all
human proteins, along with a graphical representation of
the expression of PID genes from microarray proﬁling
of organs and cells of the immune system from Gene
Expression Omnibus (GEO) (6) and Reference Database
of Immune Cells (RefDIC) (7). In addition, it incorporates
mouse studies from Mouse Genome Informatics (MGI)
(8) database for the representation of allele-based pheno-
types and anatomical systems aﬀected due to either mouse
knockouts, knockins and spontaneous mutations for the
available PID genes. With inclusion of this variety of data
for the PID disease genes, RAPID can serve as a connect-
ing link between the genotype and the phenotype.
RAPID ARCHITECTURE
RAPID is an object-oriented database. We used Zope
(http://www.zope.org) for the development of RAPID.
Zope is a leading open source web application server
and is built using the programming language Python
(http://www.python.org). MySQL is used as a backend
data storage system.
RAPID allows users access to gene-speciﬁc PID infor-
mation either by using the query page or by browsing.
RAPID can be queried by various search options includ-
ing gene symbol, protein name, mouse phenotypes,
chromosome number and PID category, and accession
numbers of entries from several database resources. The
query system includes an autocomplete option that facil-
itates quick access to the list of items in the database.
Users can browse this resource by PID genes, mutation
features such as mutation types and eﬀects. This is the ﬁrst
of its kind database to have these user-friendly features for
search and display options.
Primary information page is the default main page
of every PID gene in the RAPID. It summarizes the exter-
nal links available in the public domain such as Entrez
(9,10), HPRD, IDR, RefDIC, NetPath, OMIM (11),
HGNC (12), PDB (13), Ensembl (14) and UniProt/
Swiss-Prot (15). It also includes the disease phenotype
linked to the given gene along with the mode of inheri-
tance, alternative names of the gene function and the asso-
ciated features (Figure 1A).
ANNOTATION OF MUTATION DATA
The sequence variations in PID genes reported from
the patients are manually curated by expert biologists
from the published literature and mapped to the NCBI
RefSeq (16,17) genomic, cDNA and protein sequences
to aid the scientiﬁc community as per the recommenda-
tions for the description of sequence variants by Human
Genome Variation Society (HGVS) whose main objectives
remain to ensure documentation, collection and free dis-
tribution of all variation information (18,19). The main
criterion for inclusion of mutation data in the RAPID
from the literature is that the PID causing genes mutation
analysis has to be performed in patient samples who have
already presented with a set of PID clinical presentations
or associated features or from cell lines derived from such
patients. Carriers and asymptomatic individuals are not
included in our annotations.
MUTATION VIEWER
Each entry on the mutation has a link to the mutation
viewer, a web-based graphical user interface (GUI)
enabled tool named Mutation@A Glance, which can
be accessed at http://rapid.rcai.riken.jp/mutBrowse.cgi
(Figure 1B). It allows users to visualize the mutation posi-
tion both at the level of DNA and protein sequences as
well as homology based 3D structures with various types
of information such as SNP, protein domains and func-
tional sites (Hijikata, et al., manuscript in preparation).
GENE-EXPRESSION PROFILES
Gene-expression proﬁles of PID genes in various organs
and cells of the immune systems from a number of micro-
array experiments available in public repositories are
represented graphically for the available PID gene in the
form of histograms with immune cell types along with
the corresponding average gene-expression intensity
values. This shows the expression pattern of these genes
in immune cells, which is of relevance to immunologists
(Figure 2A).
INTERACTION NETWORKS
All the primary immunodeﬁciency disease genes have been
mapped to their direct physical interactors and, in turn,
these interactors are represented diﬀerently based on
whether an interactor is already known to be PID or
not, any of these interactors have their site of expression
in immune cells, or any lethality and/or immune system/
hematopoietic phenotypes aﬀected due to either mouse
knockout, or spontaneous mutation in mice. This infor-
mation is graphically represented in the form of nodes and
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based on the aforementioned parameters (Figure 2B).
MOUSE STUDIES
The experimental designs to study the eﬀect of the gene
variations on the disease phenotype are complicated by
the availability of ideal control subjects in case of
humans. Mouse models of human diseases are widely
used to study genotype–phenotype correlations. In
RAPID, all available PID genes are mapped to their corre-
sponding mouse ortholog from MGI to catalog any leth-
ality and/or immune system/hematopoietic phenotypes
resulting from knockout of genes or spontaneous muta-
tions (Figure 2C). These features are organized and repre-
sented in such a way that RAPID should serve as a
discovery tool for prediction of candidate PID genes,
a useful feature for immunologists, physicians and
researchers.
RAPID STATISTICS
At present, RAPID comprises total of 161 PID genes that
are involved in PID, out of which 143 PID genes are
reported with over 2455 unique mutation data. Table 1
shows the overall statistics of RAPID as of August 2008.
FUTURE DEVELOPMENTS
In addition to keeping this resource updated on a regular
basis and further elucidation of role of PID genes at mole-
cular level, we will initiate global community standard
formats for PID data exchange and validation. We will
also incorporate standardized DNA diagnosis protocols
for screening common PID, which will allow this database
to serve as an integrated informational platform for geno-
mics-based PID diagnosis.
CONCLUSIONS
RAPID provides information in an easily accessible and
decipherable ways for all users. We support and encourage
the input from PID physicians and researcher to share
their experiences in standardizing vocabulary terms for
representing anonymous patient clinical data that
enables RAPID to be used as a diagnostic tool among
physicians for early diagnosis and eﬀective treatments
A
B
Figure 1. A screenshot of the primary information page and mutation data of WAS gene in RAPID. (A) Primary information of WAS gene along
with its external resources to IDR (Immunodeﬁciency resource) and RefDIC (Reference database of Immune cells) is shown. (B) Mutation data
curated from the literature reading is shown along with the mutation viewer tool called ‘Mutation@A Glance’ to visualize the mutations both at
DNA and protein levels.
Nucleic Acids Research, 2009,Vol. 37,Database issue D865for PID patients. With community participation of inter-
ested groups, we anticipate that RAPID will become a
primary resource of PIDs in Asia.
ACKNOWLEDGEMENTS
The authors thank Yasuaki Murahashi and Miho Izawa
for their help in setting up the web servers, Advanced
Center of Computing and Communication (ACCC),
RIKEN for providing necessary computing resources,
Drs Reiko Kikuno and Fumihiko Ishikawa for their
valuable discussion, and all PID physicians involved in
the PID Japan project for their valuable input and
suggestions.
FUNDING
The Special Coordination Funds for promoting Science
and Technology, from the Ministry of Education,
Culture, Sports, and Science of Japan. Funding for open
access charge: RIKEN Research Center for Allergy and
Immunology.
Conﬂict of interest statement. None declared.
REFERENCES
1. Geha,R.S., Notarangelo,L.D., Casanova,J.L., Chapel,H.,
Conley,M.E., Fischer,A., Hammarstro ¨ m,L., Nonoyama,S.,
Ochs,H.D., Puck,J.M. et al. (2007) International Union of
Immunological Societies Primary Immunodeﬁciency Diseases
Classiﬁcation Committee. Primary immunodeﬁciency diseases: an
update from the International Union of Immunological Societies
Primary Immunodeﬁciency Diseases Classiﬁcation Committee.
J. Allergy Clin. Immunol., 120, 776–794.
2. Samarghitean,C., Valiaho,J. and Vihinen,M. (2007) IDR knowledge
base for primary immunodeﬁciencies. Immunome Res., 3,6 .
3. Marodi,L. and Notarangelo,L.D. (2007) Immunological and genetic
bases of new primary immunodeﬁciencies. Nat. Rev. Immunol., 7,
851–861.
A B
C
Figure 2. A screenshot of the expression proﬁle, interaction network and mouse studies of WAS gene. (A) Microarray gene expression proﬁle of
WAS gene in a particular human microarray data set from GEO. (B) Interaction networks of WAS from HPRD is shown along with the legends,
which explain various parameters of interactors in diﬀerent shapes and colors. (C) Primary information of mouse gene WAS is shown along with
anatomical systems aﬀected due to mutations and its allelic composition and phenotypes from MGI database.
Table 1. Overall statistics
Number of PID genes 161
Number of PID genes with mutation data 143
Number of non-redundant mutation entries 2455
Number of unique PubMed citations 762
D866 Nucleic Acids Research, 2009, Vol. 37, Databaseissue4. Cunningham-Rundles,C. and Ponda,P.P. (2005) Molecular defects
in T- and B-cell primary immunodeﬁciency diseases. Nat. Rev.
Immunol., 5, 880–892.
5. Mishra,G., Suresh,M., Kumaran,K., Kannabiran,N., Suresh,S.,
Bala,P., Shivakumar,K., Anuradha,N., Raghunath,R.,
Madhan Raghavan,T. et al. (2006) Human Protein Reference
Database - 2006 update. Nucleic Acids Res., 34, D411–D414.
6. Barrett,T. and Edgar,R. (2006) Gene expression omnibus: micro-
array data storage, submission, retrieval, and analysis. Methods
Enzymol., 411, 352–369.
7. Hijikata,A., Kitamura,H., Kimura,Y., Yokoyama,R., Aiba,Y.,
Bao,Y., Fujita,S., Hase,K., Hori,S. et al. (2007) Construction of an
open-access database that integrates cross-reference information
from the transcriptome and proteome of immune cells.
Bioinformatics, 23, 2934–2941.
8. Eppig,J.T., Blake,J.A., Bult,C.J., Kadin,J.A., Richardson,J.E. and
the members of the Mouse Genome Database Group (2007) The
Mouse Genome Database (MGD): new features facilitating a model
system. Nucleic Acids Res., 35, D630–D637.
9. Maglott,D., Ostell,J., Pruitt,K.D. and Tatusova,T. (2005) Entrez
Gene: gene-centered information at NCBI. Nucleic Acids Res., 33,
D54–D58.
10. Maglott,D., Ostell,J., Pruitt,K.D. and Tatusova,T. (2007) Entrez
Gene: gene-centered information at NCBI. Nucleic Acids Res., 35,
D26–D31.
11. Hamosh,A., Scott,A.F., Amberger,J.S., Bocchini,C.A. and
McKusick,V.A. (2005) Online Mendelian inheritance in man
(OMIM), a knowledgebase of human genes and genetic disorders.
Nucleic Acids Res., 33, D514–D517.
12. Bruford,E.A., Lush,M.J., Wright,M.W., Sneddon,T.P., Povey,S.
and Birney,E. (2008) The HGNC Database in 2008: a
resource for the human genome. Nucleic Acids Res., 36,
D445–D448.
13. Dutta,S., Burkhardt,K., Swaminathan,G.J., Kosada,T., Henrick,K.,
Nakamura,H. and Berman,H.M. (2008) Data deposition and
annotation at the worldwide protein data bank. Methods Mol. Biol.,
426, 81–101.
14. Flicek,P., Aken,B.L., Beal,K., Ballester,B., Caccamo,M., Chen,Y.,
Clarke,L., Coates,G., Cunningham,F., Cutts,T. et al. (2008)
Ensembl 2008. Nucleic Acids Res., 36, D707–D714.
15. Boeckmann,B., Bairoch,A., Apweiler,R., Blatter,M.C.,
Estreicher,A., Gasteiger,E., Martin,M.J., Michoud,K.,
O’Donovan,C., Phan,I. et al. (2003) The SWISS-PROT protein
knowledgebase and its supplement TrEMBL in 2003. Nucleic Acids
Res., 31, 365–370.
16. Pruitt,K.D., Tatusova,T. and Maglott,D.R. (2005) NCBI Reference
Sequence (RefSeq): a curated non-redundant sequence database of
genomes, transcripts and proteins. Nucleic Acids Res., 33,
D501–D504.
17. Pruitt,K.D., Tatusova,T. and Maglott,D.R. (2007) NCBI Reference
Sequence (RefSeq): a curated non-redundant sequence database of
genomes, transcripts and proteins. Nucleic Acids Res., 35, D61–D65.
18. Antonarakis,S.E. (1998) Recommendations for a nomenclature
system for human gene mutations. Nomenclature Working Group.
Hum. Mutat., 11, 1–3.
19. den Dunnen,J.T. and Antonarakis,S. E. (2000) Mutation nomen-
clature extensions and suggestions to describe complex mutations: a
discussion. Hum. Mutat., 15, 7–12.
Nucleic Acids Research, 2009,Vol. 37,Database issue D867